T-Type Calcium Channel as a New Therapeutic Target for Tremor
Authors:
- 12 April 2011
- journal article
- review article
- Published by Springer Nature in The Cerebellum
- Vol. 10 (3) , 563-569
Abstract
Voltage-gated calcium channels play an important role in many physiological and pathological processes. Accumulating studies suggest that the T-type calcium channel is a potential target for the treatment of various neurological disorders, such as epilepsy, insomnia, and neuropathic pain. Here, we highlight recent advances in our understanding of T-type calcium channel regulation and their implications for tremor disorders. Several T-type calcium channel blockers effectively suppressed experimental tremors that have been suggested to originate from either the cerebellum or basal ganglia. Among T-type calcium channel blockers that have been used clinically, the anti-tremor efficacy of zonisamide garnered our attention. Based on both basic and clinical studies, the possibility is emerging that T-type calcium channel blockers that transit into the central nervous system may have therapeutic potentials for tremor disorders.Keywords
This publication has 61 references indexed in Scilit:
- The psychosocial burden of essential tremor in an outpatient- and a community-based cohortEuropean Journal of Neurology, 2011
- T-type calcium channel antagonists suppress tremor in two mouse models of essential tremorNeuropharmacology, 2010
- Ca V 3.1 is a tremor rhythm pacemaker in the inferior oliveProceedings of the National Academy of Sciences, 2010
- Dynamic changes in cerebello-thalamo-cortical motor circuitry during progression of Parkinson's diseaseNeuroscience, 2010
- Regulation of neuronal T-type calcium channelsTrends in Pharmacological Sciences, 2009
- Discovery of 1,4-Substituted Piperidines as Potent and Selective Inhibitors of T-Type Calcium ChannelsJournal of Medicinal Chemistry, 2008
- Zonisamide for Essential TremorClinical Neuropharmacology, 2007
- Quality of life and personality in essential tremor patientsMovement Disorders, 2006
- Pramipexole in patients with Parkinson's disease and marked drug resistant tremor: a randomised, double blind, placebo controlled multicentre studyJournal of Neurology, Neurosurgery & Psychiatry, 2002
- Rhythmic activity induced by harmaline in the olivo-cerebello-bulbar system of the catBrain Research, 1973